We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
-2.28%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$253M
AUM Growth
-$4.48M
Cap. Flow
+$2.51M
Cap. Flow %
0.99%
Top 10 Hldgs %
34.71%
Holding
177
New
9
Increased
65
Reduced
89
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 12.62%
2 Financials 12.43%
3 Communication Services 4.43%
4 Healthcare 3.16%
5 Consumer Discretionary 2.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VB icon
51
Vanguard Small-Cap ETF
VB
$79.7B
$1.3M 0.51%
4,952
-253
-5% -$68.5K
CIBR icon
52
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.3B
$1.29M 0.51%
20,652
-395
-2% -$26.5K
DVY icon
53
iShares Select Dividend ETF
DVY
$23.8B
$1.21M 0.48%
8,012
-276
-3% -$41.7K
VXUS icon
54
Vanguard Total International Stock ETF
VXUS
$153B
$1.21M 0.48%
15,636
+1,695
+12% +$135K
VZ icon
55
Verizon
VZ
$182B
$1.16M 0.46%
23,183
+2,010
+9% +$93.2K
DLR icon
56
Digital Realty Trust
DLR
$64.3B
$1.13M 0.45%
6,282
-2,623
-29% -$448K
XLV icon
57
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$1.11M 0.44%
1,605
-5,744
-78% -$886K
IBB icon
58
iShares Biotechnology ETF
IBB
$9.23B
$1.1M 0.44%
6,521
-132
-2% -$22.6K
VIG icon
59
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.05M 0.42%
4,885
-314
-6% -$70K
SCHW
60
Charles Schwab
SCHW
$177B
$1.03M 0.41%
11,009
-184
-2% -$18K
SMH icon
61
VanEck Semiconductor ETF
SMH
$67.5B
$1.03M 0.41%
2,678
-104
-4% -$41.3K
PFE icon
62
Pfizer
PFE
$143B
$1.02M 0.4%
36,410
+11,965
+49% +$319K
VOE icon
63
Vanguard Mid-Cap Value ETF
VOE
$23.5B
$1.01M 0.4%
5,473
-114
-2% -$21.3K
XLU icon
64
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
$966K 0.38%
21,046
+944
+5% +$42.4K
RSPA
65
Invesco S&P 500 Equal Weight Income Advantage ETF
RSPA
$956M
$964K 0.38%
19,290
+654
+4% +$33.9K
VNQ icon
66
Vanguard Real Estate ETF
VNQ
$39.6B
$964K 0.38%
10,865
+1,343
+14% +$123K
SCHD icon
67
Schwab US Dividend Equity ETF
SCHD
$100B
$954K 0.38%
31,103
-516
-2% -$15.7K
KMI icon
68
Kinder Morgan
KMI
$71.9B
$943K 0.37%
28,130
-1,298
-4% -$40.6K
XLP icon
69
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$934K 0.37%
11,389
-307
-3% -$25.9K
PG icon
70
Procter & Gamble
PG
$349B
$892K 0.35%
6,178
+217
+4% +$32.9K
ADI icon
71
Analog Devices
ADI
$183B
$891K 0.35%
2,800
XLF icon
72
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$884K 0.35%
17,905
-412
-2% -$21.5K
QQQ icon
73
Invesco QQQ Trust
QQQ
$466B
$869K 0.34%
1,506
-58
-4% -$35.2K
VO icon
74
Vanguard Mid-Cap ETF
VO
$106B
$843K 0.33%
11,736
-1,336
-10% -$99.3K
PSP icon
75
Invesco Global Listed Private Equity ETF
PSP
$228M
$836K 0.33%
14,798
+2,774
+23% +$174K

Similar funds

O'Rourke & Company's Q1 2026 Portfolio in Review

As of Q1 2026, O'Rourke & Company held 177 positions worth $253M, down 1.7% from $257M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

O'Rourke & Company's Q1 2026 filing shows 9 new, 65 increased, 89 reduced and 6 closed positions. Its largest new stake was Berkshire Hathaway Class A: 1 share worth $718K. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $886K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Communication Services.

  • O'Rourke & Company's largest Q1 2026 buy was Berkshire Hathaway Class A: 1 share worth $718K.
  • O'Rourke & Company added most to JPMorgan Income ETF in Q1 2026, an estimated $2.2M increase.
  • O'Rourke & Company's biggest Q1 2026 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $886K.
  • O'Rourke & Company fully exited US Treasury 2 Year Note ETF in Q1 2026, selling an estimated $216K.
  • O'Rourke & Company's ten largest holdings make up 35% of its $253M portfolio in Q1 2026.
  • O'Rourke & Company opened 9 new positions and closed 6 in Q1 2026.
  • O'Rourke & Company's portfolio value fell 1.7% quarter-over-quarter to $253M.

Based on O'Rourke & Company's 13F filing for Q1 2026, filed 14 May 2026.